Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.

Autor: Kavanaugh A; A. Kavanaugh, MD, University of California San Diego, La Jolla, California, USA; akavanaugh@ucsd.edu., Westhovens RR; R.R. Westhovens, MD, PhD, KU Leuven, Skeletal Biology and Engineering Research Center, Leuven, Belgium., Winthrop KL; K.L. Winthrop, MD, MPH, Oregon Health and Science University, Portland, Oregon, USA., Lee SJ; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Tan Y; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., An D; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Ye L; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Sundy JS; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Besuyen R; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium., Meuleners L; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium., Stanislavchuk M; M. Stanislavchuk, MD, National Pirogov Memorial Medical University, Vinnytsya, Ukraine., Spindler AJ; A.J. Spindler, MD, Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina., Greenwald M; M. Greenwald, MD, Desert Medical Advances, Palm Desert, California, USA., Alten R; R. Alten, MD, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany., Genovese MC; M.C. Genovese, MD, Stanford University School of Medicine, Division of Immunology & Rheumatology, Stanford, and Gilead Sciences Inc., Foster City, California, USA.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2021 Aug; Vol. 48 (8), pp. 1230-1238. Date of Electronic Publication: 2021 Feb 01.